Cholesterol metabolism and beta-cell function;Métabolisme du cholestérol et fonction β-cellulaire

Medecine/Sciences

Volumn 26, Issue 4, 2010, Pages 385-390

  Langhi, Cédric ^a,b   Cariou, Bertrand ^c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c L INSTITUT DU THORAX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951842520     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2010264385     Document Type: Review

References (33)

1. Festa A, Williams K, D'Agostino R Jr, et al. The natural course of beta-cell function in nondiabetic and diabetic individuals: the insulin resistance atherosclerosis study. Diabetes 2006; 55: 1114-1120 (Pubitemid 44100189)
2. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006; 116: 1802-1812 (Pubitemid 44033300)
3. Linger RH, Orci L. Lipoapoptosis: its mechanism and its diseases. Biochim Biophys Acta 2002; 1585: 202-212
4. Girard J. Rôle des acides gras libres dans la sécré tion et l'action de l'insuline : mécanismes de la lipotoxicité. Med Sci (Paris) 2003 ; 19: 827-833 (Pubitemid 37127871)
5. Ishikawa M, Iwasaki Y, Yatoh S, et al. Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity. J Lipid Res 2008; 49: 2524-2534
6. Hao M, Head WS, Gunawardana SC, et al. Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes 2007; 56: 2328-2338 (Pubitemid 47358240)
7. Brunham LR, Kruit JK, Pape TD, et al. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 2007; 13: 340-347
8. Efanov AM, Sewing S, Bokvist K, Gromada J. Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells. Diabetes 2004; 53 (suppl 3) : S75-8. (Pubitemid 39564526)
9. Germ I, Dolinsky VW, Shackman JG, et al. LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J Biol Chem 2005; 280: 23024-23031
10. McNeish J, Aiello RJ, Guyot D, et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci USA 2000; 97: 4245-4250 (Pubitemid 30226118)
11. Gerstein HC, Yusuf S, Bosch J, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial, Lancet 2006; 368: 1096-1105
12. Grupping Ay, Cnop M, Van Schravendijk CF, et al. Low density lipoprotein binding and uptake by human and rat islet beta cells, Endocrinology 1997; 138: 4064-4068 (Pubitemid 27408444)
13. Cnop M, Hannaert JC, Grupping Ay, Pipeleers DG. Low density lipoprotein can cause death of islet beta-cells by its cellular uptake and oxidative modification, endocrinology 2002; 143: 3449-3453 (Pubitemid 34925718)
14. Roehrich ME, Mooser V, Lenain V, et al. Insulin-secreting beta-cell dysfunction induced by human lipoproteins. J Biol Chem 2003; 278: 18368-18375 (Pubitemid 36799458)
15. Abderrahmani A, Niederhauser G, Favre D, et al. Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells. Diabetobgia 2007 ; 50: 1304-1314 (Pubitemid 46701553)
16. Okajima F, Kurihara M, Ono C, et al. Oxidized but not acetylated low-density lipoprotein reduces preproinsulin mRNA expression and secretion of insulin from HIT-T15 cells. Biochim Biophys Acta 2005; 1687: 173-180 (Pubitemid 40228997)
17. Rutti S, Ehses JA, Sibler RA, et al. Low and high-density lipoproteins modulate function, apoptosis and proliferation of primary human and murine pancreatic beta cells, endocrinology 2009; 150: 4521-4530
18. Salaun C, James DJ, Chamberlain LH. Lipid rafts and the regulation of exocytosis. Traffic 2004; 5: 255-264
19. Lang T. SNARE proteins and "membrane rafts". J Physiol 2007; 585: 693-698
20. Xia F, Gao X, Kwan E, et al. Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J Biol Chem 2004; 279: 24685-24691 (Pubitemid 38725336)
21. Ohara-Imaizumi M, Nishiwaki C, Kikuta T, et al. Site of docking and fusion of insulin secretory granules in live MIN6 beta cells analyzed by TAT-conjugated anti-syntaxin 1 antibody and total internal reflection fluorescence microscopy. J Biol Chem 2004; 279: 8403-8408 (Pubitemid 38294733)
22. Takahashi N, Hatakeyama H, Okado H, et al. Sequential exocytosis of insulin granules is associated with redistribution of SNAP25. J Cell Biol 2004; 165: 255-262 (Pubitemid 38544528)
23. Vikman J, Jimenez-Feltstrom J, Nyman P, et al. Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol. FASEB J 2009; 23: 58-67.
24. Xia F, Xie L, Mihic A, Gao X, et al. Inhibition of cholesterol biosynthesis impairs insulin secretion and voltage-gated calcium channel function in pancreatic beta-cells, endocrinology 2008 ; 149: 5136-5145
25. Freeman DJ, Norrie J, Sattar N, et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland coronary prevention study. Circulation 2001; 103: 357-362
26. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. M Engl J Med 2008; 20; 359: 2195-2207
27. Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials, lancet 2010; 375: 735-742
28. Ishikawa M, Okajima F, Inoue N, et al. Distinct effects of pravastatin, atarvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells. J Atheroscler Thromb 2006; 13: 329-335
29. Metz SA, Rabaglia ME, Stock JB, Kowluru A. Modulation of insulin secretion from normal rat islets by inhibitors of the post-translational modifications of GTP-binding oroteins. Biochem J 1993: 295: 31-40. (Pubitemid 23298304)
30. 2+ channels in rat islet beta-cells. Br J Pharmacol 1999; 126: 1205-1213
31. Brunham LR, Kruit JK, Verchere CB, Hayden MR. Cholesterol in islet dysfunction and type 2 diabetes. ; Clin Invest 2008; 118: 403-408 (Pubitemid 351206525)
32. Schaefer EJ, Brousseau ME, Diffenderfer MR, et al. Cholesterol and apolipoprotein B metabolism in Tangier disease. Atherosclerosis 2001; 159: 231-236
33. Villarreal-Molma MT, Guilar-Salinas CA, Rodriguez-Cruz M, et al. The ATP-binding cassette transporter A1 R230C variant affects HDL cholesterol levels and BMI in the Mexican population: association with obesity and obesity-related comorbidities. Diabetes 2007; 56: 1881-1887